The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels
1 other identifier
interventional
14
1 country
1
Brief Summary
Context and Rationale: Uninterrupted sitting is associated with increased risk of diabetes, heart disease, and death, even among people who are physically active. These relationships are likely due to increases in post-meal blood sugar observed when people sit for long periods (e.g. \> 1 hour) without interruption. In contrast to sitting, standing results in large reductions in post-meal blood sugar levels. Our group has recently shown that sit-stand desks result in large (e.g. 2.5 hour/day) reductions in occupational sitting time. Taken together, these findings suggest that sit-stand desks may help to reduce post-meal blood sugar levels. However, this has yet to be examined in the field. Theoretical Approach and Objectives: The objective of this randomized crossover study is to determine whether people have lower blood sugar when using a sit-stand desk, in comparison to a desk that can only be used while sitting. Methods and Procedures: Sixteen participants will be asked to wear a continuous glucose monitor to measure their blood sugar levels during 2 separate conditions. During one condition, they will be asked to use a sit-stand desk to sit and/or stand as much as they like during 1 workday. During the other condition, they will be asked to work at a seated desk for 1 workday. Participants will be provided with identical meals to eat during each of the two conditions. We hypothesize that participants will have lower blood sugar levels on the day when they use the sit-stand desk, in comparison to the day using a traditional seated desk. Significance and Future Use: If our results support this hypothesis, this would suggest that sit-stand desks may be a useful way to reduce blood sugar levels in people at risk for diabetes. This could also lead to larger population-based interventions studying the health impact of sit-stand desks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 15, 2016
CompletedFirst Posted
Study publicly available on registry
September 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedOctober 17, 2018
October 1, 2018
1.7 years
September 15, 2016
October 12, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Postprandial Glucose
Postprandial glucose will be assessed over 1 workday in both the experimental and control conditions.
12 hours
Secondary Outcomes (2)
Objectively measured minutes of light, moderate and vigorous physical activity.
24 hours
Objectively measured minutes of sitting
24 hours
Study Arms (2)
Sit-stand desk
EXPERIMENTALDuring this condition, participants will sit or stand as much as they like throughout a workday.
Sitting
PLACEBO COMPARATORDuring this condition, participants will work in the sitting position only.
Interventions
Eligibility Criteria
You may qualify if:
- To participate in this study, participants must be between the ages of 20 and 65, and have access to a sit-stand desk (depending on your workspace, we may be able to provide you with a sit-stand desk during the study if you do not already have one).
You may not qualify if:
- Participants will be excluded if they are currently taking any diabetes medications targeting blood sugar or insulin sensitivity as this will impact our primary outcome of postprandial glucose. Participants will also be excluded if they are unable to stand or walk independently, as these are secondary outcomes in the present study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Prince Edward Island
Charlottetown, Prince Edward Island, C1A 4P3, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 15, 2016
First Posted
September 23, 2016
Study Start
September 1, 2016
Primary Completion
June 1, 2018
Study Completion
September 1, 2018
Last Updated
October 17, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share
No.